• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性纤维遇见肝细胞癌:发酵的阴暗面。

When Soluble Fibers Meet Hepatocellular Carcinoma: The Dark Side of Fermentation.

机构信息

Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.

Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany; Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, 81675 Munich, Germany.

出版信息

Cell Metab. 2018 Nov 6;28(5):673-675. doi: 10.1016/j.cmet.2018.10.009.

DOI:10.1016/j.cmet.2018.10.009
PMID:30403986
Abstract

Fermentation of dietary soluble fibers by our gut microbiota generates short-chain fatty acids (SCFAs) and metabolites, upholding health and being a valuable food supplement. Recently, in Cell, Singh et al. (2018) discovered that fermentable, dietary soluble fibers (e.g., inulin) induced cholestasis and hepatocellular carcinoma (HCC) while improving metabolic dysfunction.

摘要

我们的肠道微生物群发酵膳食可溶性纤维会产生短链脂肪酸(SCFAs)和代谢物,维持健康,是一种有价值的食品补充剂。最近,Singh 等人在《细胞》杂志上发现,可发酵的膳食可溶性纤维(如菊粉)在改善代谢功能障碍的同时,会诱导胆汁淤积和肝细胞癌(HCC)。

相似文献

1
When Soluble Fibers Meet Hepatocellular Carcinoma: The Dark Side of Fermentation.可溶性纤维遇见肝细胞癌:发酵的阴暗面。
Cell Metab. 2018 Nov 6;28(5):673-675. doi: 10.1016/j.cmet.2018.10.009.
2
Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer.可溶性膳食纤维失调的微生物发酵可诱发胆汁淤积性肝癌。
Cell. 2018 Oct 18;175(3):679-694.e22. doi: 10.1016/j.cell.2018.09.004.
3
Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota.万古霉素可预防肠道菌群失调小鼠中发酵纤维诱导的肝癌。
Gut Microbes. 2020 Jul 3;11(4):1077-1091. doi: 10.1080/19490976.2020.1743492. Epub 2020 Mar 30.
4
Fermentable fibers induce rapid macro- and micronutrient depletion in Toll-like receptor 5-deficient mice.可发酵纤维可导致 Toll 样受体 5 缺陷型小鼠快速耗尽宏量和微量营养素。
Am J Physiol Gastrointest Liver Physiol. 2020 May 1;318(5):G955-G965. doi: 10.1152/ajpgi.00349.2019. Epub 2020 Mar 23.
5
The impact of long-term dietary pattern of fecal donor on in vitro fecal fermentation properties of inulin.粪便供体的长期饮食模式对菊粉体外粪便发酵特性的影响。
Food Funct. 2016 Apr;7(4):1805-13. doi: 10.1039/c5fo00987a.
6
In vitro batch fecal fermentation comparison of gas and short-chain fatty acid production using "slowly fermentable" dietary fibers.使用“慢发酵”膳食纤维进行体外批量粪便发酵比较气体和短链脂肪酸的产生。
J Food Sci. 2011 Jun-Jul;76(5):H137-42. doi: 10.1111/j.1750-3841.2011.02172.x. Epub 2011 Apr 27.
7
Comparative effects of cellulose and soluble fibers (pectin, konjac glucomannan, inulin) on fecal water toxicity toward Caco-2 cells, fecal bacteria enzymes, bile acid, and short-chain fatty acids.纤维素和可溶性纤维(果胶、魔芋葡甘聚糖、菊粉)对 Caco-2 细胞粪便水毒性、粪便细菌酶、胆汁酸和短链脂肪酸的比较影响。
J Agric Food Chem. 2010 Sep 22;58(18):10277-81. doi: 10.1021/jf102127k.
8
Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice.无菌小鼠日粮中菊粉对细菌生长、短链脂肪酸生成及肝脏脂质代谢的影响
J Nutr Biochem. 2015 Sep;26(9):929-37. doi: 10.1016/j.jnutbio.2015.03.010. Epub 2015 May 1.
9
The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects.菊粉这种可发酵纤维能增加健康受试者餐后血清中的短链脂肪酸含量,降低游离脂肪酸和胃饥饿素水平。
Appl Physiol Nutr Metab. 2010 Feb;35(1):9-16. doi: 10.1139/H09-119.
10
Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota.普雷沃氏菌属和拟杆菌属主导的肠道微生物群的膳食纤维利用能力存在差异。
Sci Rep. 2017 Jun 1;7(1):2594. doi: 10.1038/s41598-017-02995-4.

引用本文的文献

1
Gut microbiota in the development and progression of chronic liver diseases: Gut microbiota-liver axis.肠道微生物群在慢性肝病发生发展中的作用:肠道微生物群-肝脏轴
World J Hepatol. 2025 Mar 27;17(3):104167. doi: 10.4254/wjh.v17.i3.104167.
2
Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease.肠-肝轴和胰高血糖素样肽-1 受体激动剂在代谢功能障碍相关脂肪性肝病治疗中的作用。
World J Gastroenterol. 2024 Jun 21;30(23):2964-2980. doi: 10.3748/wjg.v30.i23.2964.
3
Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches.
微生物群在内分泌相关疾病中的影响:从发育到新型治疗方法
Biomedicines. 2024 Jan 18;12(1):221. doi: 10.3390/biomedicines12010221.
4
The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases.肠道微生物衍生的短链脂肪酸丁酸在肝胆疾病中的作用。
Am J Pathol. 2023 Oct;193(10):1455-1467. doi: 10.1016/j.ajpath.2023.06.007. Epub 2023 Jul 6.
5
Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.肠-肝轴介导的肝癌发生机制:特别关注肠道微生物群的作用。
Cancer Sci. 2021 Nov;112(11):4433-4443. doi: 10.1111/cas.15142. Epub 2021 Sep 27.